Work

S4854 Patient Outcomes With Intensified Risankizumab Maintenance Dosing for Crohn’s Disease: A Case Series

Year: 2025

Type: conference-abstract

Source: The American Journal of Gastroenterology

DOI: 10.14309/01.ajg.0001146876.67242.0c

Authors: Fnu Rashi, Najwa El-Nachef

Language: English

Topic: Inflammatory Bowel Disease

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7110996682

Cites:

Cited by:

Related to: